Xilio Therapeutics has hired Yariv Houvras to serve as its chief medical officer. The company announced the appointment in a recent personnel update. Houvras joins Xilio from Tubulis, where he held the position of senior vice president of clinical and translational development. This move marks a significant leadership change for the pharmaceutical firm. STAT+ highlighted the hire in its weekly column tracking executive changes in the industry. The publication noted that Houvras is a notable addition to the company's executive team. No further details about his specific responsibilities or start date were provided in the announcement.